77% of financial organizations experienced a cyberattack in the past year, higher than the 68% in other industries, as per a Netwrix report.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
